Haemonetics Corp
HAE· NYSE
HAEHaemonetics Corp
Filed Nov 3, 2011 · 10-Q · 33 days after period end · 0000950123-11-094857
| Metric | Q2 2011 | Q2 2010 | Q2 2009 |
|---|---|---|---|
| Revenue | $179.45M | $166.83M | $157.07M |
| Net Income | $13.88M | $21.34M | $18.05M |
| EPS Diluted | $0.27 | $0.85 | $0.69 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
ended Oct 1, 2011 · filed Nov 3, 2011 · 33 d after period end
